Rezan Koçak Ulucaköy (2024) “Can serum granulocyte-macrophage colony-stimulating factor and CCL17 levels be a marker of disease activation in spondyloarthritis?”, Archives of Rheumatology, 39(3), pp. 368–374. doi: 10.46497/ArchRheumatol.2024.10360.